Skip to main content
. 2022 Sep 29;17(21):e202200341. doi: 10.1002/cmdc.202200341

Table 4.

Inhibition of Giardia duodenalis metabolism by Library 4 Robenidine analogues possessing di‐, tri‐ and poly‐substituted aromatic rings (3447).[a]

Antigiardial activity

Compound

R

MLC [μM] (24 h)

IC50 [μM] (5 h)

Antibacterial activity (Y/N)[b]

Toxicity (Y/N) (% growth control)[c]

Selectivity ratio[d]

34

2,4‐Cl

3.13

2.49

N

Y[e] (55.8±4.3)

>10.0

35

3,5‐Cl

25

11.6

N

36

2,6‐Cl

N

37

2,5‐F

N

38

3,4‐F

8.3

1.2

Y

39

2,3,4,5,6‐F

N

40

2‐NHCOCH3, 4‐Cl

25

0.8

N

Y (83.1±4.4)

>31.3

41

2‐Br, 4,5‐OCH3

2.8

0.2

N

N

>125

42

3‐Br, 4,5‐OCH3

3.13

2.7

N

Y[e]

>9.3

43

2‐OH, 4‐N(CH3)2

Y

44

3,4‐OCH3

>25

24.9

N

45

3‐NO2, 4‐OH

N

46

3‐OH, 4‐OCH3

N

47

3‐OCH3, 4‐OH

>25

>25

Y

[a] Toxicity (CaCo‐2 and Vero cells) and antimicrobial assays performed at 25 μM; MLC: minimum lethal concentration; ‘–’ not tested, as inhibitory activity at 25 μM<50 %. [b] MSRA and VRE. [c] Percent CaCo‐2 cell growth (25 μM); compounds are indicated as toxic if >10 % cells are affected. [d] Higher ratios indicate a more selective compound. [e] Toxicity assessed with Vero cells, not CaCo‐2 cells.